Wall Street brokerages forecast that Veeco Instruments Inc. (NASDAQ:VECO) will report sales of $134.65 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Veeco Instruments’ earnings. The highest sales estimate is $135.00 million and the lowest is $134.30 million. Veeco Instruments posted sales of $131.87 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 2.1%. The business is expected to issue its next quarterly earnings report on Thursday, November 1st.
According to Zacks, analysts expect that Veeco Instruments will report full-year sales of $583.70 million for the current year, with estimates ranging from $581.40 million to $586.00 million. For the next financial year, analysts expect that the firm will post sales of $587.50 million per share, with estimates ranging from $560.00 million to $615.00 million. Zacks’ sales averages are an average based on a survey of sell-side analysts that follow Veeco Instruments.
Top 10 Growth Stocks For 2019: MEDIFAST INC(MED)
Advisors' Opinion:- [By Lisa Levin]
Medifast, Inc. (NYSE: MED) shares were also up, gaining 25 percent to $124.60 after the company reported strong Q1 results and raised its FY18 guidance.
- [By Logan Wallace]
MediBloc [QRC] (CURRENCY:MED) traded 11.6% lower against the US dollar during the 24 hour period ending at 20:00 PM Eastern on August 29th. One MediBloc [QRC] token can now be bought for about $0.0066 or 0.00000100 BTC on popular exchanges including Gate.io, Coinrail and Bibox. MediBloc [QRC] has a total market cap of $19.65 million and $279,707.00 worth of MediBloc [QRC] was traded on exchanges in the last 24 hours. During the last week, MediBloc [QRC] has traded 27.8% lower against the US dollar.
- [By Sean Williams]
Meanwhile, Medifast's (NYSE:MED) share price has tripled since the beginning of March. Medifast's second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures).
- [By Logan Wallace]
MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. MediBloc [QRC20]’s official website is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The official message board for MediBloc [QRC20] is medium.com/@MediBloc. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here.
- [By Joseph Griffin]
MediBloc [QRC] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. Its genesis date was January 3rd, 2014. MediBloc [QRC]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC] is medibloc.org/en. MediBloc [QRC]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC] is /r/MediBloc and the currency’s Github account can be viewed here. The official message board for MediBloc [QRC] is medium.com/@MediBloc.
Top 10 Growth Stocks For 2019: Nordstrom Inc.(JWN)
Advisors' Opinion:- [By Chris Lange]
Nordstrom Inc. (NYSE: JWN) is scheduled to release its most recent quarterly results after the markets close on Thursday. The consensus estimates call for $0.44 in earnings per share (EPS) on $3.46 billion in revenue. The fiscal first quarter of last year reportedly had EPS of $0.37 and $3.35 billion in revenue.
- [By Motley Fool Transcription]
Nordstrom, Inc. (NYSE:JWN) Q2 2018 Earnings Conference Call August 16, 2018, 4:45 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Jim Crumly]
As for individual stocks, NVIDIA (NASDAQ:NVDA) reported yet another quarter of red-hot growth, and Nordstrom (NYSE:JWN) surprised observers with solid quarterly results.
- [By Stephan Byrd]
Nordstrom, Inc. (NYSE:JWN) insider Ken Worzel sold 13,703 shares of the company’s stock in a transaction on Wednesday, April 11th. The shares were sold at an average price of $48.97, for a total value of $671,035.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
- [By Jeremy Bowman]
A lot has changed since then, however. J.C. Penney badly underperformed its own comparable sales target in the second half of 2016, as comparable sales fell instead of hitting the 3-4% mark the company had projected. Its peers continued to struggle -- Macy's (NYSE:M), Kohl's (NYSE:KSS), and Nordstrom (NYSE:JWN) all reported declining comps in the fourth quarter, and Macy's said last year it would close 100 stores.
- [By ]
Cramer and the AAP team are sharing a positive research note on Norstrom (JWN) , and their analysis. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Top 10 Growth Stocks For 2019: Buffalo Wild Wings Inc.(BWLD)
Advisors' Opinion:- [By Steve Symington]
That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.
- [By Peter Graham]
A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:
Top 10 Growth Stocks For 2019: Intuitive Surgical Inc.(ISRG)
Advisors' Opinion:- [By Keith Speights]
You might have thought that Intuitive Surgical (NASDAQ:ISRG) would have a hard time beating its performance in 2017. After all, the maker of robotic surgical systems reported record revenue. Its stock soared nearly 73%.
- [By Garrett Baldwin]
Earnings season is well underway. And if you're looking to make real money, the time to get started is now. Money Morning Quantitative Specialist Chris Johnson argues the markets are at a tipping point. And with just a few smart plays in today's classic stock picker's market… you can pull in triple-digit gains with just a small investment. Read those picks right here.
The Top Stock Market Stories for Thursday This morning, the U.S. Department of Labor said that weekly jobless claims came in at 207,000 for the week. That figure is below the 220,000 jobless claims expected by economists and brings U.S. unemployment claims to a 48.5-year low. It's a big day of earnings reports, as dozens of blue chip companies will report results from the June-ending quarter. The biggest name today will be Microsoft Corp. (Nasdaq: MSFT), which reports earnings after the bell. Wall Street expects that the technology giant will report earnings of $1.07 per share. Analysts project quarterly revenue of $29.17 billion. Three Stocks to Watch Today: PM, IBM, AA International Business Machines (NYSE: IBM) stock added 2.5% in pre-market hours after Big Blue topped Wall Street earnings and revenue expectations. The tech giant continues to post positive results as it accelerates its turnaround efforts. IBM reported earnings per share of $3.08, a figure that beat estimates by $0.04 per share. It also reported quarterly revenue of $20.0 billion, a figure that surpassed estimates of $19.85 billion. Shares of Alcoa Corp. (NYSE: AA) fell 2% this morning. The aluminum manufacturer slashed its 2018 outlook due to falling prices and the recent round of metals tariffs introduced by the Trump administration. But there could be more pain in sight. Today, the U.S. Justice Department will hold a hearing that aims to determine whether vehicle and light truck imports present a national security threat to the United States. The hearing is due to President Trump's pledge to hit European auto man - [By Keith Speights]
But that doesn't mean such stocks don't exist. Intuitive Surgical (NASDAQ:ISRG) stands out as one stock that investors should be able to buy and never sell. Here are 12 reasons why.
- [By Motley Fool Staff]
Intuitive Surgical (NASDAQ:ISRG) reported fourth-quarter earnings and it delivered a small miss on profits. Wall Street, no shock, dinged its stock price accordingly.
Top 10 Growth Stocks For 2019: TrueBlue Inc.(TBI)
Advisors' Opinion:- [By Logan Wallace]
Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
- [By Joseph Griffin]
Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.
- [By Logan Wallace]
Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Trueblue (TBI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Transcribers]
TrueBlue Inc (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
No comments:
Post a Comment